Ichthyosis: clinical manifestations and practical treatment options

V Oji, H Traupe - American journal of clinical dermatology, 2009 - Springer
V Oji, H Traupe
American journal of clinical dermatology, 2009Springer
Ichthyoses constitute a large group of cornification disorders that affect the entire
integument. The skin is characterized by visible scaling and in many cases by inflammation,
for example, in bullous/keratinopathic ichthyosis or Netherton syndrome. From the viewpoint
of classification it is useful to distinguish nonsyndromic from syndromic types of ichthyosis.
Ichthyosis vulgaris and recessive X-linked ichthyosis are common disorders—often of
delayed onset, in contrast to congenital ichthyoses, which belong to the group of rare …
Abstract
Ichthyoses constitute a large group of cornification disorders that affect the entire integument. The skin is characterized by visible scaling and in many cases by inflammation, for example, in bullous/keratinopathic ichthyosis or Netherton syndrome. From the viewpoint of classification it is useful to distinguish nonsyndromic from syndromic types of ichthyosis. Ichthyosis vulgaris and recessive X-linked ichthyosis are common disorders—often of delayed onset, in contrast to congenital ichthyoses, which belong to the group of rare diseases and present at birth with either the features of collodion membrane or congenital ichthyosiform erythroderma.
The diagnostic steps are based on clinical data, analyses such as the steroid sulfatase activity test, skin biopsies, and genetic results. However, the dramatic increase in knowledge about the pathophysiology of these conditions has not led to a curative therapy so far. The therapeutic management is multidisciplinary and involves ichthyosis patient organizations in many countries. The mainstay of treatment remains with moisturizing creams containing, for example, urea, lactic acid and other humectants and keratolytics, regular bathing, and mechanical scale removal. Patients with lamellar ichthyosis or ichthyosiform erythroderma in particular profit from oral therapy with retinoids or retinoic acid metabolism-blocking agents.
Springer